Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Solid Tumor Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Solid Tumor Drug Market Overview

    • 1.1 Product Overview and Scope of Solid Tumor Drug
    • 1.2 Solid Tumor Drug Segment by Type
      • 1.2.1 Global Solid Tumor Drug Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Small Molecules
      • 1.2.3 Biologics
    • 1.3 Solid Tumor Drug Segment by Application
      • 1.3.1 Solid Tumor Drug Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Oncology
      • 1.3.3 Neurology
      • 1.3.4 Radiology
      • 1.3.5 Others
    • 1.4 Global Solid Tumor Drug Market Size Estimates and Forecasts
      • 1.4.1 Global Solid Tumor Drug Revenue 2015-2026
      • 1.4.2 Global Solid Tumor Drug Sales 2015-2026
      • 1.4.3 Solid Tumor Drug Market Size by Region: 2020 Versus 2026

    2 Global Solid Tumor Drug Market Competition by Manufacturers

    • 2.1 Global Solid Tumor Drug Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Solid Tumor Drug Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Solid Tumor Drug Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Solid Tumor Drug Manufacturing Sites, Area Served, Product Type
    • 2.5 Solid Tumor Drug Market Competitive Situation and Trends
      • 2.5.1 Solid Tumor Drug Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Solid Tumor Drug Players (Opinion Leaders)

    3 Solid Tumor Drug Retrospective Market Scenario by Region

    • 3.1 Global Solid Tumor Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Solid Tumor Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Solid Tumor Drug Market Facts & Figures by Country
      • 3.3.1 North America Solid Tumor Drug Sales by Country
      • 3.3.2 North America Solid Tumor Drug Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Solid Tumor Drug Market Facts & Figures by Country
      • 3.4.1 Europe Solid Tumor Drug Sales by Country
      • 3.4.2 Europe Solid Tumor Drug Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Solid Tumor Drug Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Solid Tumor Drug Sales by Region
      • 3.5.2 Asia Pacific Solid Tumor Drug Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Solid Tumor Drug Market Facts & Figures by Country
      • 3.6.1 Latin America Solid Tumor Drug Sales by Country
      • 3.6.2 Latin America Solid Tumor Drug Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Solid Tumor Drug Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Solid Tumor Drug Sales by Country
      • 3.7.2 Middle East and Africa Solid Tumor Drug Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Solid Tumor Drug Historic Market Analysis by Type

    • 4.1 Global Solid Tumor Drug Sales Market Share by Type (2015-2020)
    • 4.2 Global Solid Tumor Drug Revenue Market Share by Type (2015-2020)
    • 4.3 Global Solid Tumor Drug Price Market Share by Type (2015-2020)
    • 4.4 Global Solid Tumor Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Solid Tumor Drug Historic Market Analysis by Application

    • 5.1 Global Solid Tumor Drug Sales Market Share by Application (2015-2020)
    • 5.2 Global Solid Tumor Drug Revenue Market Share by Application (2015-2020)
    • 5.3 Global Solid Tumor Drug Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Solid Tumor Drug Business

    • 6.1 AstraZeneca
      • 6.1.1 Corporation Information
      • 6.1.2 AstraZeneca Description, Business Overview and Total Revenue
      • 6.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 AstraZeneca Products Offered
      • 6.1.5 AstraZeneca Recent Development
    • 6.2 Biogen
      • 6.2.1 Biogen Solid Tumor Drug Production Sites and Area Served
      • 6.2.2 Biogen Description, Business Overview and Total Revenue
      • 6.2.3 Biogen Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Biogen Products Offered
      • 6.2.5 Biogen Recent Development
    • 6.3 Baxter
      • 6.3.1 Baxter Solid Tumor Drug Production Sites and Area Served
      • 6.3.2 Baxter Description, Business Overview and Total Revenue
      • 6.3.3 Baxter Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Baxter Products Offered
      • 6.3.5 Baxter Recent Development
    • 6.4 Celgene Corporation
      • 6.4.1 Celgene Corporation Solid Tumor Drug Production Sites and Area Served
      • 6.4.2 Celgene Corporation Description, Business Overview and Total Revenue
      • 6.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Celgene Corporation Products Offered
      • 6.4.5 Celgene Corporation Recent Development
    • 6.5 Abbott Laboratories
      • 6.5.1 Abbott Laboratories Solid Tumor Drug Production Sites and Area Served
      • 6.5.2 Abbott Laboratories Description, Business Overview and Total Revenue
      • 6.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Abbott Laboratories Products Offered
      • 6.5.5 Abbott Laboratories Recent Development
    • 6.6 Pfizer Inc
      • 6.6.1 Pfizer Inc Solid Tumor Drug Production Sites and Area Served
      • 6.6.2 Pfizer Inc Description, Business Overview and Total Revenue
      • 6.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Pfizer Inc Products Offered
      • 6.6.5 Pfizer Inc Recent Development
    • 6.7 Amgen Limited & Amgen Ireland Limited
      • 6.6.1 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Production Sites and Area Served
      • 6.6.2 Amgen Limited & Amgen Ireland Limited Description, Business Overview and Total Revenue
      • 6.6.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Amgen Limited & Amgen Ireland Limited Products Offered
      • 6.7.5 Amgen Limited & Amgen Ireland Limited Recent Development
    • 6.8 Bristol-Myers Squibb Company
      • 6.8.1 Bristol-Myers Squibb Company Solid Tumor Drug Production Sites and Area Served
      • 6.8.2 Bristol-Myers Squibb Company Description, Business Overview and Total Revenue
      • 6.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Bristol-Myers Squibb Company Products Offered
      • 6.8.5 Bristol-Myers Squibb Company Recent Development
    • 6.9 GlaxoSmithKline plc.
      • 6.9.1 GlaxoSmithKline plc. Solid Tumor Drug Production Sites and Area Served
      • 6.9.2 GlaxoSmithKline plc. Description, Business Overview and Total Revenue
      • 6.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 GlaxoSmithKline plc. Products Offered
      • 6.9.5 GlaxoSmithKline plc. Recent Development
    • 6.10 F. Hoffmann-La Roche Ltd.
      • 6.10.1 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Production Sites and Area Served
      • 6.10.2 F. Hoffmann-La Roche Ltd. Description, Business Overview and Total Revenue
      • 6.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 F. Hoffmann-La Roche Ltd. Products Offered
      • 6.10.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 6.11 Eli Lilly and Company
      • 6.11.1 Eli Lilly and Company Solid Tumor Drug Production Sites and Area Served
      • 6.11.2 Eli Lilly and Company Solid Tumor Drug Description, Business Overview and Total Revenue
      • 6.11.3 Eli Lilly and Company Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Eli Lilly and Company Products Offered
      • 6.11.5 Eli Lilly and Company Recent Development
    • 6.12 Johnson & Johnson
      • 6.12.1 Johnson & Johnson Solid Tumor Drug Production Sites and Area Served
      • 6.12.2 Johnson & Johnson Solid Tumor Drug Description, Business Overview and Total Revenue
      • 6.12.3 Johnson & Johnson Solid Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Johnson & Johnson Products Offered
      • 6.12.5 Johnson & Johnson Recent Development

    7 Solid Tumor Drug Manufacturing Cost Analysis

    • 7.1 Solid Tumor Drug Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Solid Tumor Drug
    • 7.4 Solid Tumor Drug Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Solid Tumor Drug Distributors List
    • 8.3 Solid Tumor Drug Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Solid Tumor Drug Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Solid Tumor Drug by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Solid Tumor Drug by Type (2021-2026)
    • 10.2 Solid Tumor Drug Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Solid Tumor Drug by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Solid Tumor Drug by Application (2021-2026)
    • 10.3 Solid Tumor Drug Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Solid Tumor Drug by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Solid Tumor Drug by Region (2021-2026)
    • 10.4 North America Solid Tumor Drug Estimates and Projections (2021-2026)
    • 10.5 Europe Solid Tumor Drug Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Solid Tumor Drug Estimates and Projections (2021-2026)
    • 10.7 Latin America Solid Tumor Drug Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Solid Tumor Drug Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      This report focuses on Solid Tumor Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Solid Tumor Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
      At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

      The following manufacturers are covered:
      AstraZeneca
      Biogen
      Baxter
      Celgene Corporation
      Abbott Laboratories
      Pfizer Inc
      Amgen Limited & Amgen Ireland Limited
      Bristol-Myers Squibb Company
      GlaxoSmithKline plc.
      F. Hoffmann-La Roche Ltd.
      Eli Lilly and Company
      Johnson & Johnson

      Segment by Regions
      North America
      Europe
      China
      Japan

      Segment by Type
      Small Molecules
      Biologics

      Segment by Application
      Oncology
      Neurology
      Radiology
      Others
      Buy now